SCHEMBL23343244

SCHEMBL23343244

C=N/C=C(\C)c1ccccn1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.52
▸ ALDH1A1 P00352 3/20 0.50
▸ CES2 O00748 1/20 0.44
▸ CES1 P23141 1/20 0.44
▸ LMNA P02545 1/20 0.42
▸ NAPRT Q6XQN6 1/20 0.42
▸ P4HTM Q9NXG6 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ TOP2A P11388 2/20 0.41
▸ RAB9A P51151 5/20 0.40
▸ SMN1; SMN2 Q16637 3/20 0.40
▸ TDP1 Q9NUW8 2/20 0.40
▸ PTBP1 P26599 1/20 0.40
▸ OPRK1 P41145 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ HSP90AA1 P07900 2/20 0.39
▸ KMT2A Q03164 3/20 0.39
▸ GAA P10253 3/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ MAPT P10636 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20402442 0.86 KDM4E (0.46) KDM4EALDH1A1CES2CES1LMNA
SCHEMBL19001629 0.83 KDM4E (0.46) KDM4EALDH1A1CES2CES1LMNA
SCHEMBL18789868 0.80 KDM4E (0.46) KDM4EALDH1A1CES2CES1LMNA
SCHEMBL6158138 0.79 ALDH1A1 (0.55) KDM4EALDH1A1CES2CES1LMNA
SCHEMBL9160142 0.78 ALDH1A1 (0.59) KDM4EALDH1A1CES2CES1LMNA
SCHEMBL3729714 0.78 ALDH1A1 (0.59) KDM4EALDH1A1CES2CES1LMNA
SCHEMBL3729713 0.78 ALDH1A1 (0.59) KDM4EALDH1A1CES2CES1LMNA
SCHEMBL18738976 0.77 KDM4E (0.47) KDM4EALDH1A1CES2CES1LMNA
SCHEMBL20168971 0.76 KDM4E (0.42) KDM4EALDH1A1CES2CES1LMNA
SCHEMBL10465175 0.76 ALDH1A1 (0.52) KDM4EALDH1A1CES2CES1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11005051-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2021-05-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11005051-B2 Organic electroluminescent materials and devices TAAR1, TRMT1L, TERT KDM4E 2000/4885ALDH1A1 661/4885CES2 1589/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback